WallStreetZenWallStreetZen

NASDAQ: ERNA
Ernexa Therapeutics Inc Stock Ownership - Who owns Ernexa Therapeutics?

OverviewEarningsRevenueDividendOwnership

Insider buying vs selling

Have Ernexa Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Charles Cherington10% Owner2025-06-0921,241,163$0.11
$2.23MBuy
Charles Cherington10% Owner2025-04-023,768,397$0.11
$395.68kBuy
Charles Cherington10% Owner2024-10-292,819,546$0.50
$1.41MBuy

1 of 1

ERNA insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when ERNA insiders and whales buy or sell their stock.

ERNA Shareholders

What type of owners hold Ernexa Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Charles Cherington543.09%41,659,743$66.24MInsider
Fidelity National Financial Inc500.99%38,430,766$61.10MInsider
Jeffrey Alan Berg272.36%20,892,428$33.22MInsider
Trinad Capital Master Fund Ltd116.02%8,900,093$14.15MInsider
Joseph J. Farricielli Jr.88.06%6,754,611$10.74MInsider
Fidelity National Financial Inc 169.20%5,307,911$8.44MInsider
Matthew Angel45.49%3,489,666$5.55MInsider
John D. Halpern38.15%2,926,551$4.65MInsider
Yiannis Monovoukas21.92%1,681,359$2.67MInsider
Nicholas Jason Singer19.07%1,463,036$2.33MInsider

1 of 3

ERNA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ERNA0.04%99.96%Net BuyingNet Buying
CARM9.53%73.98%
IBIO8.49%91.51%Net Buying
BRTX0.24%99.76%Net Selling
MTNB0.91%99.09%
View Top Biotech Stocks

Ernexa Therapeutics Stock Ownership FAQ

Who owns Ernexa Therapeutics?

Ernexa Therapeutics (NASDAQ: ERNA) is owned by 0.65% institutional shareholders, 1,780.39% Ernexa Therapeutics insiders, and 0.00% retail investors. Charles Cherington is the largest individual Ernexa Therapeutics shareholder, owning 41.66M shares representing 543.09% of the company. Charles Cherington's Ernexa Therapeutics shares are currently valued at $66.24M.

If you're new to stock investing, here's how to buy Ernexa Therapeutics stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.